(Reuters) - Merck & Co Inc said on Monday it started a new clinical trial to evaluate the safety and effectiveness of its experimental oral drug MK-8931 in patients with mild-to-moderate Alzheimer's disease.
via Reuters: Health News Read More Here..
No comments:
Post a Comment